Fundraising Fox

Dr Colin Story

Investor

Advisory Board Member at UK Innovation & Science Seed Fund

About

Colin Story joined UKI2S as an advisory board member in November 2023 and has a background in business development within engineering biology organisations. He started his career at GE Healthcare in product development and project management before moving to Isis Innovation, where he built a business development team managing over 200 medical science innovations from Oxford University, and later served as Operations Director at OrganOx. He co-founded OxSonics in 2013 and was its CEO from 2014 to 2022, raising £25m across three rounds.

Invests in

BiotechMedical Devices

Investments

Board seats

BetaGlue Technologies SpAHox Therapeutics Limited

Per the firm's website.

Colleagues at UK Innovation & Science Seed Fund